Nano-encapsulated tryptanthrin derivative for combined anticancer therapy via inhibiting indoleamine 2,3-dioxygenase and inducing immunogenic cell death
出版年份 2019 全文链接
标题
Nano-encapsulated tryptanthrin derivative for combined anticancer therapy via inhibiting indoleamine 2,3-dioxygenase and inducing immunogenic cell death
作者
关键词
-
出版物
Nanomedicine
Volume 14, Issue 18, Pages 2423-2440
出版商
Future Medicine Ltd
发表日期
2019-09-06
DOI
10.2217/nnm-2019-0074
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
- (2018) Junjie Wu et al. CANCER LETTERS
- Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6.
- (2018) Clelia Madeddu et al. HAEMATOLOGICA
- Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6.
- (2018) Clelia Madeddu et al. HAEMATOLOGICA
- Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
- (2018) Bing Feng et al. ADVANCED MATERIALS
- Improved Cancer Immunochemotherapy via Optimal Co-delivery of Chemotherapeutic and Immunomodulatory Agents
- (2018) Yichao Chen et al. MOLECULAR PHARMACEUTICS
- The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
- (2017) Lieve Brochez et al. EUROPEAN JOURNAL OF CANCER
- Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
- (2017) Alice Coletti et al. MedChemComm
- Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
- (2016) Xiao Zhao et al. BIOMATERIALS
- Immunization with functionalized carbon nanotubes enhances the antibody response against mode antigen ovalbumin
- (2016) Xinfeng Zhu et al. IMMUNOLOGY LETTERS
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
- (2016) Yichao Chen et al. Nature Communications
- Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies?
- (2015) Cédric Rébé et al. Future Oncology
- Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1
- (2015) Yi-Hui Peng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
- (2015) Jigang Wang et al. Nature Communications
- Synthesis and evaluation of the antiplasmodial activity of tryptanthrin derivatives
- (2015) Liliane Abodo Onambele et al. International Journal for Parasitology-Drugs and Drug Resistance
- 585: The synthetic Tryptanthrin analogue suppresses STATs signalling and induces caspase dependent apoptosis via ERK up regulation in human leukemia HL-60 cells
- (2014) A. Pathania et al. EUROPEAN JOURNAL OF CANCER
- Phagocytic Uptake of Oxidized Heme Polymer Is Highly Cytotoxic to Macrophages
- (2014) Rohitas Deshmukh et al. PLoS One
- Discovery of Tryptanthrin Derivatives as Potent Inhibitors of Indoleamine 2,3-Dioxygenase with Therapeutic Activity in Lewis Lung Cancer (LLC) Tumor-Bearing Mice
- (2013) Shuangshuang Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tryptanthrin-Loaded Nanoparticles for Delivery into Cultured Human Breast Cancer Cells, MCF7: the Effects of Solid Lipid/Liquid Lipid Ratios in the Inner Core
- (2011) Yi-Ping Fang et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype
- (2011) Gaetano Cairo et al. TRENDS IN IMMUNOLOGY
- Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines
- (2010) Sung-tsai Yu et al. ACTA PHARMACOLOGICA SINICA
- Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer
- (2010) Pei-Du Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
- (2010) X. Liu et al. BLOOD
- Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model
- (2009) Eddy W. Yue et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started